Novo Nordisk and Forma Therapeutics, Holdings Inc. announced that they have entered into a definitive agreement under which Novo Nordisk will acquire Forma Therapeutics for $ 20 per share in cash, which represents a total equity value of $ 1.1bn
Background: Congenital fibrinogen deficiency (CFD) is a rare coagulation disorder placing patients at increased bleeding risk. Human fibrinogen concentrate (HFC) represents current standard of care for fibrinogen replacement in CFD, however, limited data are available on HFC for prophylactic administration before/during surgery.
The FDA has approved the Selenia Dimensions System,from Hologic Inc., the first X-ray mammography device that provides three-dimensional (3-D) images...
The FDA announced that the Mobilett Mira, a portable digital X-ray system from Siemens, has received 510(k) approval. The Mira�s...
ICU Medical Inc.and Pfizer Inc.announced that they have entered into a definitive agreement under which ICU Medical will acquire all...
Philips has received 510(k) clearance from the FDA to market its AlluraClarity Image Guidance X Ray imaging system in the...
The FDA has given approval for SenoClaire, an X Ray Imaging device, from GE Healthcare, that uses breast tomosynthesis for...
Introduction: Pseudomyxoma peritonei (PMP) is a rare entity that usually results from a perforated primary appendiceal tumor. The established intervention for PMP is cytoreductive surgery with hyperthermic intraperitoneal...
The FDA has given 510(k) approval of Mozart with TomoSpec imaging system, from Kubtec, a breast specimen radiography system with...
The FDA has issued 510(k) approval for the Planmed Verity Extremity Scanner. Planmed's Verity system is intended to be used...